Prosecution Insights
Last updated: May 29, 2026
Application No. 18/396,721

CONTINUOUS BLOOD GLUCOSE MEASUREMENT APPARATUS

Non-Final OA §102§112
Filed
Dec 27, 2023
Priority
Jul 31, 2018 — RE 10-2018-0089331 +2 more
Examiner
MESSERSMITH, ERIC J
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
I-Sens Inc.
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
503 granted / 723 resolved
At TC average
Strong +25% interview lift
Without
With
+24.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
31 currently pending
Career history
749
Total Applications
across all art units

Statute-Specific Performance

§101
3.2%
-36.8% vs TC avg
§103
73.3%
+33.3% vs TC avg
§102
8.6%
-31.4% vs TC avg
§112
11.1%
-28.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 723 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 12 is objected to because of the following informalities: one “wherein” should be deleted so as to not have “wherein” appearing consecutively. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 8 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. As to claim 8, it is not clear what being “configured to move in a direction of crossing a movement direction of the plunger body” means. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 7-10 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2017/0188912 A1 to Halac et al. (“Halac”). As to claim 7, Halac discloses a continuous blood glucose measurement apparatus, comprising: a body attachable unit configured to be attachable to a body to measure blood glucose (see [0007] – “The base can comprise an adhesive configured to couple the sensor module to the skin.”); and an applicator comprising a main case (Fig 105, element 392v) to which a press button (Fig 105, element 760) is mounted, a shooting plate configured to be movable by the press button (see Fig 106, element 752 – tab is planar and as such is a plate that allows the device to be actuated or “shot” into the body), and a plunger body disposed inside the main case and configured to move the body attachable unit from a first location to a second location (see Fig 110-114, element 150 w), wherein the plunger body is engagedly fixed at the first location by the shooting plate, and is configured to move to the second location by being released from engagement according to movement of the shooting plate (see [0642] – only when element is 760 engages plate 752 can the plunger body 150 w move from the first position to the second position). As to claim 8, Halac further discloses wherein the shooting plate is configured to move in a direction of crossing a movement direction of the plunger body (see Figs. 110-111 and note that the plate moves diagonally, which appears to be a direction that crosses a movement direction of the plunger body). As to claim 9, Halac further discloses wherein the shooting plate is configured to move in a direction perpendicular to a movement direction of the plunger body (see Figs. 110-111 and note that the plate moves diagonally, which appears to be a direction perpendicular to a movement direction of the plunger body). As to claim 10 Halac further discloses wherein: the main case comprises an outer case (see Fig 110, element 392w), wherein the press button is mounted to one side of the outer case (see Fig 107, element 760) ; and an inner case coupled to an inside of the outer case, the inner case configured to guide a linear movement path of the plunger body (see Figs 113-114, element 152w), and the shooting plate is configured to horizontally move by being supported by the inner case (see Figs 107-109 showing the plate moving both horizontally and vertically). Allowable Subject Matter Claims 11-14 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric Messersmith whose telephone number is (571)270-7081. The examiner can normally be reached M-F, 830am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JACQUELINE CHENG can be reached at 571-272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIC J MESSERSMITH/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Dec 27, 2023
Application Filed
Dec 31, 2025
Non-Final Rejection (signed) — §102, §112
Feb 11, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12629060
METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM
12m to grant Granted May 19, 2026
Patent 12611121
SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING
3y 4m to grant Granted Apr 28, 2026
Patent 12582772
LQG ARTIFICIAL PANCREAS CONTROL SYSTEM AND RELATED METHOD
2y 6m to grant Granted Mar 24, 2026
Patent 12576212
MEDICINE INJECTION AND DISEASE MANAGEMENT SYSTEMS, DEVICES, AND METHODS
3y 8m to grant Granted Mar 17, 2026
Patent 12569168
SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING
4y 8m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
94%
With Interview (+24.7%)
3y 4m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 723 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month